Carol Routledge


Carol Routledge

Venture Partner




Tel: +44 20 7421 7091




Carol Routledge joined SV as a Venture partner, focused on the DDF, in 2015.


Prior to this, Carol was Head of Translational Medicine in Biopharm Discovery, Biopharm R&D. She has over 25 years’ experience in preclinical and clinical research and development for both NCEs and biologics. She holds a degree from Nottingham University and a PhD in neuropharmacology. Carol’s career has spanned various positions in major pharmaceutical and biotechnology companies both in the UK and in the US including ICI, Syntex, Wyeth, SmithKline Beecham, BTG and GSK.


Her focus has been on drug discovery and development across a number of different therapeutic areas particularly in the areas of neuroscience and immuno-inflammatory diseases with an emphasis on translational medicine.